Testing a brain-connected implant to help some blind people see
Part of Brain & nervous system, Eyes & vision, Injuries & trauma clinical trials.
This early safety study tests an implanted device placed in the brain to help people with very limited sight (no or minimal light). It focuses on whether the implant can be safely used and whether it may support vision-related signals over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have no light perception or only bare light perception in both eyes
- Your blindness started after you had normal or near-normal sight as a child, and you’ve been blind for at least one year
- Your eye condition and exam match the study’s very specific vision limits (not certain exception cases like birth-long total no light)
- Your brain scan (MRI) is normal, and you do not have metal implants or devices that block MRI (like a pacemaker)
- You can join all study visits and agree to audio/video recording for pre-screening and consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new AI system designed to improve what people with visual prostheses 'see.' If you have an implanted device like the Argus II or Orion, you may be able to help by coming to the lab for several days of vision testing.
This trial studies a device that may help people with severe blindness by sending signals to the brain’s visual areas. You may be eligible if you’re an adult with long-term, severe vision loss and good overall health and can complete testing for several months.
This study tests whether a device that converts visual information into sounds or touch can help people with vision loss perform simple visual tasks. It also looks at how the brain changes in response to this training.
This trial tests a small telescope implant for people with advanced age-related macular degeneration (AMD) in both eyes. It aims to improve central vision in the eye where the implant is placed.
This study tests a device that is surgically implanted in the eye of people with late-stage age-related macular degeneration (AMD). It also uses vision training with a telescope-like tool to see if the treatment can improve day-to-day vision.
This study looks at how the brain works when people who are blind (from birth or early childhood) touch and move. It uses an MRI brain scan to compare responses, aiming to better understand learning and brain processing in early visual loss.
Hear when a new Optic Nerve Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.